Presentation

Total Page:16

File Type:pdf, Size:1020Kb

Presentation ACUTE CIRCULATORY FAILURE Inability for the cells to get enough oxygen in relation to their oxygen needs OXYGEN AVAILABILITY I am in SHOCK Arterial hypotension Altered cutaneous perfusion (mottled, clammy skin) I am in Altered mentation (obtundation, disorientation, SHOCK confusion) Arterial hypotension Altered cutaneous perfusion (mottled, clammy skin) I am in Altered mentation (obtundation, disorientation, SHOCK confusion) Arterial hypotension Altered cutaneous perfusion Decreased (mottled, clammy skin) urine output I am in Altered mentation (obtundation, disorientation, SHOCK confusion) Arterial hypotension Altered cutaneous perfusion Decreased (mottled, clammy skin) urine output GASTRIC TONOMETRY Influence of monitoring systems on outcome Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Gutierrez G et al., Lancet 339:195-9, 1992 EBM ? 260 patients (APACHE II 15-25) pH > 7.35 pH < 7.35 YES NO YES NO Survival 58 % 42 % 37 % 36 % P < 0.01 P = NS I am in Altered mentation (obtundation, disorientation, SHOCK confusion) Hyperlactatemia > 2 mEq/L Arterial hypotension Altered cutaneous perfusion Decreased (mottled, clammy skin) urine output SEVERITY CIRCULATORY SHOCK ELEVATED LACTATE Distributive Hypovolemic Cardiogenic Obstructive Sepsis Hypovolemia Heart Pulm. failure embolism Infection Pericardial Arrhythmias effusion LACTATE Hospital mortality, % 172,723 blood lactate measurements in 7,155 critically ill patients (4 hospitals) 100 90 80 70 60 Initial 50 lactate 40 levels 30 20 10 0 <1.2 1.2-1.5 1.5-2.0 2.0-4.0 4.0-6.0 >6.0 mEq/L or LACTATE mMol/L 6 Single measurement 5 4 3 2 1 0 TIME SKIN RBC BRAIN GUT MUSCLE PRODUCTION 0.8 mmol/kg/h lactate (1300 mmol/day for 70 kg) ELIMINATION LIVER OTHER TISSUES 2/3 1/3 Blood lactate levels are influenced by lactate production more than by lactate clearance PRODUCTION CLEARANCE TIME NATURAL HISTORY OF LACTIC ACIDOSIS AFTER GRAND-MAL SEIZURES Orringer et al, N Engl J Med 297: 796-9, 1977 Lactate levels, mEq/L 14 13 12 11 CLEARANCE 10 9 8 7 6 0 10 20 30 40 50 60 70 Time, min N = 8 pts (adapted) Serial lactate determinations Vincent et al, Crit Care Med 11: 449-51, 1983 In optimal conditions (good response to fluid administration) Lactate, mEq/L 6 5 4 3 2 10 % decrease in 1 hour 1 0 0 1 2 3 4 5 6 7 TIME, hours LACTATE TIME Conclusions: Better outcome associated with decreasing blood lactate concentrations - consistent throughout the clinical studies - not limited to septic patients - valid regardless of the initial value - in all groups, changes relatively slow, so that lactate measurements every 1–2 hrs are probably sufficient in most acute conditions. 2019 104 patients Independent risk factors of 30‐day mortality (multivariable logistic regression) ➢ Δ Lac <2.5%/h, ➢ Baseline lactate >4 mmol/L and ➢ High SAPS III score HEMODYNAMIC STABILIZATION The goals Adequate MAP without vasopressors The three windows of tissue perfusion Normal skin perfusion Urine output > 0.5 mL/kg/h Preserved mental status Lactate levels normal or decreasing Hypotension Mortality lactate measured late No hypotension lactate measured late Hypotension lactate measured early No hypotension lactate measured early Hospital mortality, % 172,723 blood lactate measurements in 7,155 critically ill patients (4 hospitals) 100 90 80 70 60 Initial 50 lactate 40 levels 30 20 10 0 <1.2 1.2-1.5 1.5-2.0 2.0-4.0 4.0-6.0 >6.0 SEVERITY CIRCULATORY SHOCK ELEVATED LACTATE Distributive Hypovolemic Cardiogenic Obstructive Sepsis Hypovolemia Heart Pulm. failure embolism Infection Pericardial Arrhythmias effusion The triangle of shock Arterial hypotension SHOCK Altered tissue Increeased perfusion blood lactate (oliguria, altered mentation, Microcirculatory abnormalities impaired skin perfusion) Vincent JL et al, Crit Care 2012 Arterial hypotension Signs of tissue hypoperfusion ? (oliguria, altered mentation, cutaneous vasoconstriction...) present absent blood lactate > 2 mEq/L < 1.5 mEq/L chronic hypotension ? syncope (if transient) circulatory shock arterial catheter central venous catheter THE FOUR PATHOPHYSIOLOGIC MECHANISMS I am in SHOCK HYPOVOLEMIC hemorrhage, trauma cholera... CARDIOGENIC myocardial infarction terminal cardiomyopathy valvular disease OBSTRUCTIVE severe arrhythmias pulmonary embolism tamponade tension pneumothorax DISTRIBUTIVE inflammatory response (mediators) Arterial pressure = cardiac output x vascular tone ARTERIAL HYPOTENSION CARDIAC OUTPUT HIGH LOW (decreased vascular tone) Hypovolemic Distributive (trauma, bleeding, diarrhea…) (sepsis, anaphylaxis, pancreatitis…) Cardiogenic (heart failure, valvular disease, major arrhythmia…) Obstructive (tamponade, massive pulm. embolism …) SEPTIC SHOCK ALTERED O2 EXTRACTION INCREASED O2 DEMAND IMPAIRED MYOCARDIAL CONTRACTILITY O2 CONSUMPTION O2 DELIVERY 2019 SOSD Br J Anaesth. 2014 Nov;113(5):740-7 Salvage / Rescue Optimisation Stabilisation De-escalation Echo/Doppler CVP Monitoring ScvO2 Cardiac Output Signs of fluid responsiveness Fluid challenge SOSD SOSD JL Vincent & D De Backer TIME SOSD Oxygen Central venous catheter Maintenance Tracheal intubation? Fluid challenge (CVP) Diuretics? Fluids Initial fluid loading Arterial catheter Ultrafiltration? Norepinephrine Norepinephrine Taper down for MAP 65-70 mmHg for adequate MAP norepinephrine Cardiac outputCO / SvO2/ ScvO2 Echocardiography Non-invasive ventilatiion In shock states High flow oxygen In shock states 442 patients mechanical ventilation either with FiO2 at 1·0 (hyperoxia) or FiO2 set to target a SaO2 of 88–95% (normoxia) during the first 24 h …in nature, and by contrast with virtually all other biochemical abnormalities, no animal is ever exposed to hyperoxia. A recommendation to keep SpO2within the low-normal range of 92–96% in all critically ill patients is easily achievable with minimum effort and little cost. The VIP rule (Weil and colleagues) entilate Oxygen administation V mechanical ventilation ? nfuse IV fluids I Blood transfusions ? Vasopressor agents ? Pump Dobutamine ? 2018 ‘Fluid overload’ Too much fluid, but where? The patient has anasarca, but develops septic shock... 2018 The terms hypervolemia and fluid overload are often used interchangeably, yet they do not have the same meaning. “Fluid overload” may vaguely refer to excess total body water content associated with edema, but it would be better if the term were avoided completely. The word “hypervolemia” is sufficient to indicate an excess in circulating blood volume and, if present, needs to be properly documented before a strategy of fluid restriction and/or diuretics is applied. AN EDEMATOUS PATIENT MAY BE HYPOVOLEMIC Beware of the terms ➢ Hypervolemia ➢ Fluid overload SOSD Oxygen Central venous catheter Maintenance Tracheal intubation? Fluid challenge (CVP) Diuretics? Fluids Initial fluid loading Arterial catheter Ultrafiltration? Norepinephrine Norepinephrine Taper down for MAP 65-70 mmHg for adequate MAP norepinephrine Cardiac outputCO / SvO2/ ScvO2 Echocardiography Br J Anaesth. 2014 Nov;113(5):740-7 Salvage / Rescue Optimisation Stabilisation De-escalation Echo/Doppler CVP Monitoring ScvO2 Cardiac Output Signs of fluid responsiveness Fluid challenge MOF Hypovolemia + vasopressors FLUID ADMINISTRATION INCREASE IN INCREASE IN CARDIAC FILLING PRESSURES CARDIAC OUTPUT EDEMA FORMATION INCREASE IN ARTERIAL PRESSURE IMPROVED TISSUE PERFUSION DECREASE IN HEART RATE INCREASED URINE OUTPUT Does this patient need IV fluid ? Arterial pressure 85/45 mmHg maybe Heart rate 117 / min maybe Cardiac output 3.9 L/min maybe Urine output 10 mL/h maybe ScvO2 60 % maybe Lactate 3.1 mEq/L maybe Central venous pressure 6 mmHg maybe MORE FLUIDS ? Fully controlled Spontaneous breathing mechanival ventilation (with or without mechanical ventilation) Anesthetized or Deeply sedated/paralyzed Pulse Pressure Variation (PPV) Stroke Volume Variation (SVV) End-expiratory pause Sigh AIRWAY PRESSURE MECHANICAL cmH2O VENTILATION 0 SPONTANEOUS FLUID RESPONSIVENESS Transient increase in intrathoracic pressure Transient decrease in venous return (+ reduced RV ejection) AIRWAY PRESSURE AIRWAY Decreased RV stroke volume Decreased LV stroke volume (after a few beats) Transient decrease in pulse pressure ARTERIAL PRESSURE ARTERIAL FLUID RESPONSIVENESS STROKE VOLUME END-DIASTOLIC VOLUME FLUID RESPONSIVENESS AP monitoring Pulse Pressure Variation (PPV) CO monitoring Stroke Volume Variation (SVV) FLUID RESPONSIVENESS PPV / SVV REQUIREMENTS Mechanical ventilation No spontaneous breathing activity No major arrhythmia Relatively large tidal volume No significant tachypnea No intraabdominal hypertension 2018 Anesth Analg 2019 CI Healthy volunteers (young) 4.0 3.2 10 16 PAOP, mmHg Respiratory variation in IVC diameter Limited ability to predict fluid responsiveness, particularly in spontaneously ventilating patients. A negative test cannot be used to rule out fluid responsiveness. 2017 Neuromuscular blockade agents were routinely used N = 319 pts MORE FLUIDS ? Fully controlled Spontaneous breathing mechanival ventilation (with or without mechanical ventilation) Anesthetized or Deeply sedated/paralyzed Fluid Pulse Pressure Variation (PPV) challenge Stroke Volume Variation (SVV) End-expiratory pause Sigh FLUID ADMINISTRATION WILL FLUIDS BE BENEFICIAL ? Obviously yes Not sure Fluid loading Fluid challenge The goal of fluid administration Minimal increase Increase in cardiac filling pressures in cardiac output No increase Increase in edema in DO2 Improved tissue perfusion FLUID ADMINISTRATION What we desire The LOWEST hydrostatic pressures associated
Recommended publications
  • Central Venous Catheters Insertion – Assisting
    Policies & Procedures Title:: CENTRAL VENOUS CATHETERS INSERTION – ASSISTING LPN / RN: Entry Level Competency I.D. Number: 1073 Authorization Source: Nursing Cross Index: [] Pharmacy Nursing Committee Date Revised: February 2018 [] MAC Motion #: Date Effective: March, 1997 [x] Former SHtnHR Nursing Practice Scope: SKtnHR Acute Care Committee Any PRINTED version of this document is only accurate up to the date of printing 13-May-19. Saskatoon Health Region (SHR) cannot guarantee the currency or accuracy of any printed policy. Always refer to the Policies and Procedures site for the most current versions of documents in effect. SHR accepts no responsibility for use of this material by any person or organization not associated with SHR. No part of this document may be reproduced in any form for publication without permission of SHR. HIGH ALERT: Central line-associated bloodstream infection (CLABSI) continues to be one of the most deadly and costly hospital-associated infections. – Institute for Healthcare Improvement DEFINITIONS Central Venous Catheter (CVC) - A venous access device whose tip dwells in a great vessel. Central Line Associated Blood Stream Infection (CLABSI)- is a primary blood stream infection (BSI) in a patient that had a central line within the 48-hour period before the development of a BSI and is not bloodstream related to an infection at another site. 1. PURPOSE 1.1 To minimize the risks of central line-associated bloodstream infections and other complications associated with the insertion of central venous catheters. 2. POLICY 2.1 This policy applies to insertion of all central venous catheters (CVCs). 2.2 All licensed staff assisting with the insertion of CVCs will be educated in CVC care and prevention of CLABSI.
    [Show full text]
  • Comparison of the Mortality Prediction of Different ICU Scoring Systems
    Egyptian Journal of Chest Diseases and Tuberculosis (2015) xxx, xxx–xxx HOSTED BY The Egyptian Society of Chest Diseases and Tuberculosis Egyptian Journal of Chest Diseases and Tuberculosis www.elsevier.com/locate/ejcdt www.sciencedirect.com ORIGINAL ARTICLE Comparison of the mortality prediction of different ICU scoring systems (APACHE II and III, SAPS II, and SOFA) in a single-center ICU subpopulation with acute respiratory distress syndrome Abdelbaset Saleh a,*, Magda Ahmed b, Intessar Sultan c, Ahmed Abdel-lateif d a Chest Department, Saudi German Hospital Al-Madinah, Chest Medicine, Mansoura University, Egypt b Chest Medicine, Taiba University and Mansoura University, Egypt c Internal Medicine, Taiba University and Cairo University, Egypt d ICU, Saudi German Hospital Al-Madinah, Egypt Received 14 April 2015; accepted 17 May 2015 KEYWORDS Abstract Background: Scoring systems can be used to define critically ill patients, estimate their Acute respiratory distress prognosis, help in clinical decision making, guide the allocation of resources and estimate the qual- syndrome; ity of care in the ICU. APACHE II; Purpose: This study compared the predictive accuracy of four predictive scoring systems in the APACHE III; ICU. SAPS II; Methods: A prospective cohort study including consecutively admitted 110 adult ICU patients SOFA (88 males) with ARDS from Saudi German Hospital, Madinah, was performed from June 2013 to January 2015. The median age of the patients was 38 years, the median duration of illness before ICU admission was 6 days, and the median duration of ICU admission was 27 days. The APACHE II, APACHE III, SAPS II, and SOFA scores were calculated based on the worst values during the first 24 h of admission.
    [Show full text]
  • Intubation Through a Laryngeal Mask Airway by Fiberoptic Bronchoscope in an Infant with a Mass at the Base of the Tongue − a Case Report −
    대한마취과학회지 2008; 54: S 43~6 □ 영문논문 □ Korean J Anesthesiol Vol. 54, No. 3, March, 2008 Intubation through a Laryngeal Mask Airway by Fiberoptic Bronchoscope in an Infant with a Mass at the Base of the Tongue − A case report − Department of Anesthesiology and Pain Medicine, Anesthesiology and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea Ji Eun Kim, M.D., Chul Ho Chang, M.D., and Yong-Taek Nam, M.D. Failed or difficult tracheal intubation remains an important cause of mortality and morbidity during anesthesia, especially in infants with anatomical or pathological abnormalities of the airway. We report on a 4.1 kg, 85-day-male infant with a thyroglossal duct cyst at the tongue base who could not be conventionally ventilated and intubated in the supine position. The infant was intubated with a 3-mm endotracheal tube through the laryngeal mask airway (LMA) with guidance of a fiberoptic bronchoscope (FOB). However, the pilot balloon did not pass through the 1.5-mm LMA conduit. After cutting the pilot balloon, we removed the LMA and inserted a central venous catheter guide-wire through the endotracheal tube to increase the endotracheal tube to 3.5 mm. This maneuver allowed us to secure the airway without further problems. (Korean J Anesthesiol 2008; 54: S 43~6) Key Words: fiberoptic bronchoscope, infant, intubation, laryngeal mask airway, thyroglossal duct cyst. Failed or difficult tracheal intubation is an important cause conventional laryngoscopy.8) of mortality and morbidity during anesthesia.1-3) Difficulties are In the present report, we describe the successful intubation more frequent in pediatric patients because of their anatomical with LMA and FOB under the aid of central venous catheter variations.4) Tracheal intubation of infants with various anato- guide wire in a 4.1 kg, 85-day-male infant, who could not be mical and pathological abnormalities of the airway can be a conventionally ventilated and intubated.
    [Show full text]
  • The Simplified Acute Physiology Score III Is Superior to The
    Hindawi Publishing Corporation Current Gerontology and Geriatrics Research Volume 2014, Article ID 934852, 9 pages http://dx.doi.org/10.1155/2014/934852 Review Article The Simplified Acute Physiology Score III Is Superior to the Simplified Acute Physiology Score II and Acute Physiology and Chronic Health Evaluation II in Predicting Surgical and ICU Mortality in the ‘‘Oldest Old’’ Aftab Haq,1 Sachin Patil,2 Alexis Lanteri Parcells,1 and Ronald S. Chamberlain1,2,3 1 Saint George’s University School of Medicine, West Indies, Grenada 2 Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA 3 Department of Surgery, University of Medicine and Dentistry of New Jersey (UMDNJ), 94 Old Short Hills Road Livingston, Newark, NJ 07039, USA Correspondence should be addressed to Ronald S. Chamberlain; [email protected] Received 25 August 2013; Revised 3 November 2013; Accepted 2 December 2013; Published 17 February 2014 Academic Editor: Giuseppe Zuccala Copyright © 2014 Aftab Haq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Elderly patients in the USA account for 26–50% of all intensive care unit (ICU) admissions. The applicability of validated ICU scoring systems to predict outcomes in the “Oldest Old” is poorly documented. We evaluated the utility of three commonly used ICU scoring systems (SAPS II, SAPS III, and APACHE II) to predict clinical outcomes in patients > 90 years. 1,189 surgical procedures performed upon 951 patients > 90 years (between 2000 and 2010) were analyzed.
    [Show full text]
  • The Nurses Group Poster Session
    THE NURSES GROUP POSTER SESSION NP001 This abstract outlines the development and testing of an Family members’ experiences of different caring education program for family carers of individuals about to organizations during allogeneic hematopoietic stem cells undergo BMT. The project aimed to increase carer confidence transplantation - A qualitative interview study in supporting newly discharged blood and marrow transplant K. Bergkvist1,*, J. Larsen2, U.-B. Johansson1, J. Mattsson3, (BMT) recipients through an interactive education program. B. Fossum1 Method: Evaluation methodology was used to examine the 1 2 impact on carer confidence. Brief questionnaires to assess level Sophiahemmet University, Red Cross University College, fi 3Oncology and Pathology, Karolinska Institutet, Stockholm, of con dence were implemented pre- and post- each session; fi Sweden questions were speci c to the content of that session. Following completion of the program an overall evaluation Introduction: Home care after allogeneic hematopoietic stem survey was also completed. The education sessions were developed drawing on evidence from literature, unit specific cell transplantation (HSCT) has been an option for over ’ 15 years. Earlier studies have shown that home care is safe practice guidelines and the team s expertise. Carers of and has medical advantages. Because of the complex and individuals who were about to receive, or currently receiving intensive nature of the HSCT, most patients require a family BMT, were invited to attend the education program. member to assist them with their daily living. Today, there is a Completing the evaluation was not a program requirement. limited knowledge about family members’ experiences in Results: Up to 14 carers attended each session.
    [Show full text]
  • ADOPTED REGULATION of the STATE BOARD of NURSING LCB File No. R122-01 Effective December 14, 2001 AUTHORITY: §§1-7, 13 And
    ADOPTED REGULATION OF THE STATE BOARD OF NURSING LCB File No. R122-01 Effective December 14, 2001 EXPLANATION – Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY: §§1-7, 13 and 14, NRS 632.120; §§8-12, NRS 632.120 and 632.237. Section 1. Chapter 632 of NAC is hereby amended by adding thereto a new section to read as follows: “Physician assistant” means a person who is licensed as a physician assistant by the board of medical examiners pursuant to chapter 630 of NRS. Sec. 2. NAC 632.010 is hereby amended to read as follows: 632.010 As used in this chapter, unless the context otherwise requires, the words and terms defined in NAC 632.015 to 632.101, inclusive, and section 1 of this regulation have the meanings ascribed to them in those sections. Sec. 3. NAC 632.071 is hereby amended to read as follows: 632.071 “Prescription” means authorization to administer medications or treatments issued by an advanced practitioner of nursing, a licensed physician, a licensed physician assistant, a licensed dentist or a licensed podiatric physician in the form of a written or oral order, a policy or procedure of a facility or a written protocol developed by the prescribing practitioner. Sec. 4. NAC 632.220 is hereby amended to read as follows: 632.220 1. A registered nurse shall perform or supervise: --1-- Adopted Regulation R122-01 (a) The verification of an order given for the care of a patient to ensure that it is appropriate and properly authorized and that there are no documented contraindications in carrying out the order; (b) Any act necessary to understand the purpose and effect of medications and treatments and to ensure the competence of the person to whom the administration of medications is delegated; and (c) The initiation of intravenous therapy and the administration of intravenous medication.
    [Show full text]
  • Quality Improvement in the Surgical Intensive Care Unit
    critical care QUALITY IMPROVEMENT IN THE SURGICAL INTENSIVE CARE UNIT Mark R. Hemmila, MD, and Wendy L. Wahl, MD Ernest A. Codman, MD, was a Boston surgeon who became Examples of BCBSM/BCN regional CQI successes include dissatisfied with the lack of outcomes evaluation for patient a decline in risk-adjusted morbidity from 13.1% in 2005 to care provided at the Massachusetts General Hospital.1 He 10.5% in 2009 for general and vascular surgery patients firmly believed in recording diagnostic and treatment errors (p < .0001) and a fall in overall complications for bariatric while linking these errors to outcomes for the purpose of surgery from 8.7% to 6.6% associated with a significant drop improving clinical care. In 1911, Dr. Codman resigned his in 30-day mortality from 2007 to 2009 (p = .004).6 Improve- position at the Massachusetts General Hospital and opened ments in quality were achieved in the interventional cardiol- his own hospital, focused on recording, grouping, and report- ogy collaborative with reductions in contrast-associated ing of medical errors. In his lifetime, Codman’s reforming nephropathy, stroke, and in-hospital myocardial infarction. efforts brought him ridicule, scorn, and censure and dimin- Lastly, the cardiac surgery collaborative improved its compos- ished his ability to earn a living. It is ironic that we now ite quality score for Michigan participants from average on a honor him as a hero and early champion of quality and national basis to achievement of a three-star rating from the patient safety.2 Dr. Codman believed that “every hospital Society of Thoracic Surgeons.
    [Show full text]
  • CVP)/Right Atrial (RA) Catheter: Pressure Measurement, Removal
    Critical Care Specialty Procedural Guideline D-6.1 Central Venous (CVP)/Right Atrial (RA) Catheter: Pressure Measurement, Removal Policy Statement(s) Pressure Measurement • CVP or RA represents right ventricular (RV) function and is used to evaluate right-sided heart preload. Normal 2-8 mmHg. • Monitoring trends in CVP is more meaningful than a single reading. • Central venous access may be obtained in a variety of places: • internal jugular vein • subclavian vein • femoral vein • external jugular vein • CVP waveform normally has a, c, v waves present. Removal • An RN can remove a central venous catheter with a physician's order. • The central venous catheter tip is obtained for culture : • Upon order of a physician. • If there is evidence of infection at the site. • If the patient's temperature is elevated. • After removal, cleanse CVP or RA catheter site with alcohol and apply an occlusive dressing. Procedural Guideline(s) • Pressure Measurement • Removal Pressure Measurement 1. Assure transducer has been leveled, zeroed and the square wave test is adequate. 2. Observe pressure tracing (Figure 1) to validate CVP tracing. 3. Pressure readings may be obtained with the patient's head elevated up to 45 degrees as long as the transducer is leveled to the phlebostatic axis. Figure 1 4. CVP waveform consists of (Figure 2): • A wave which correlates with PR interval of the ECG tracing. • C wave which correlates with the end of QRS. • V wave which correlates with after the T wave. 5. Measure the mean of the A wave to obtain pressure. Figure 2 6. The mean of the A wave generally will be consistent with the monitor value displayed unless large A waves are present.
    [Show full text]
  • Hydrocortisone Reduces 28-Day Mortality in Septic Patients: a Systemic Review and Meta- Analysis
    Open Access Original Article DOI: 10.7759/cureus.4914 Hydrocortisone Reduces 28-day Mortality in Septic Patients: A Systemic Review and Meta- analysis Waqas J. Siddiqui 1 , Praneet Iyer 2 , Ghulam Aftab 3 , FNU Zafrullah 4 , Muhammad A. Zain 5 , Kadambari Jethwani 6 , Rabia Mazhar 3 , Usman Abdulsalam 7 , Abbas Raza 6 , Muhammad O. Hanif 8 , Esha Sharma 9 , Sandeep Aggarwal 8 1. Cardiology / Nephrology, Drexel University College of Medicine, Philadelphia, USA 2. Internal Medicine, University of Tennessee Health Sciences Center, Memphis, USA 3. Internal Medicine, Orange Park Medical Center, Orange Park, USA 4. Internal Medicine, Steward Carney Hospital, Tufts University School of Medicine, Boston, USA 5. Internal Medicine, Sheikh Zayed Medical College and Hospital, Rahim Yar Khan, PAK 6. Internal Medicine, Drexel University, Philadelphia, USA 7. Internal Medicine, Steward Carney Hospital, Boston, USA 8. Nephrology, Drexel University, Philadelphia, USA 9. Internal Medicine, George Washington University, Washington D.C., USA Corresponding author: Ghulam Aftab, [email protected] Abstract The goal of this study was to determine the utility of hydrocortisone in septic shock and its effect on mortality. We performed a systematic search from inception until March 01, 2018, according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines comparing hydrocortisone to placebo in septic shock patients and selected studies according to our pre-defined inclusion and exclusion criteria. Four reviewers extracted data into the predefined tables in the Microsoft Excel (Microsoft Corp., New Mexico, US) sheet. We used RevMan software to perform a meta-analysis and draw Forest plots. We used a random effects model to estimate risk ratios.
    [Show full text]
  • Investigating Novel and Conventional Biomarkers for Post-Resuscitation Prognosis: the Role of Cytokeratin-18, Neuron-Specifc Enolase, and Lactate
    Investigating Novel and Conventional Biomarkers for Post-resuscitation Prognosis: The Role of Cytokeratin-18, Neuron-specic Enolase, and Lactate Beata Csiszar 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Almos Nemeth Anaesthesiology and Intensive Therapy Unit, Uzsoki Hospital, University of Semmelweis, Budapest, Hungary Zsolt Marton 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Janos Riba 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Peter Csecsei Department of Neurosurgery, University of Pecs, Medical School, Pecs, Hungary Tihamer Molnar Department of Anaesthesiology and Intensive Care, University of Pecs, Medical School, Pecs, Hungary Robert Halmosi 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Laszlo Deres 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Tamas Koszegi Department of Laboratory Medicine, University of Pecs, Medical School, Pecs, Hungary Barbara Sandor 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Kalman Toth 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Peter Kenyeres ( [email protected] ) 1st Department of Medicine, Division of Cardiology, University of Pecs, Medical School, Pecs, Hungary Research Article Keywords: cardiopulmonary
    [Show full text]
  • Hemodynamic Profiles Related to Circulatory Shock in Cardiac Care Units
    REVIEW ARTICLE Hemodynamic profiles related to circulatory shock in cardiac care units Perfiles hemodinámicos relacionados con el choque circulatorio en unidades de cuidados cardiacos Jesus A. Gonzalez-Hermosillo1, Ricardo Palma-Carbajal1*, Gustavo Rojas-Velasco2, Ricardo Cabrera-Jardines3, Luis M. Gonzalez-Galvan4, Daniel Manzur-Sandoval2, Gian M. Jiménez-Rodriguez5, and Willian A. Ortiz-Solis1 1Department of Cardiology; 2Intensive Cardiovascular Care Unit, Instituto Nacional de Cardiología Ignacio Chávez; 3Inernal Medicine, Hospital Ángeles del Pedregal; 4Posgraduate School of Naval Healthcare, Universidad Naval; 5Interventional Cardiology, Instituto Nacional de Cardiología Ignacio Chávez. Mexico City, Mexico Abstract One-third of the population in intensive care units is in a state of circulatory shock, whose rapid recognition and mechanism differentiation are of great importance. The clinical context and physical examination are of great value, but in complex situa- tions as in cardiac care units, it is mandatory the use of advanced hemodynamic monitorization devices, both to determine the main mechanism of shock, as to decide management and guide response to treatment, these devices include pulmonary flotation catheter as the gold standard, as well as more recent techniques including echocardiography and pulmonary ultra- sound, among others. This article emphasizes the different shock mechanisms observed in the cardiac care units, with a proposal for approach and treatment. Key words: Circulatory shock. Hemodynamic monitorization.
    [Show full text]
  • Central Venous Access Device Policy (Central Line Policy)
    Policy No: OP41 Version: 3.0 Name of Policy: Central Venous Access Device Policy (Central Line Policy) Effective From: 24/10/2013 Date Ratified 26/09/2013 Ratified Infection, Prevention and Control Committee Review Date 01/09/2015 Sponsor Director of Nursing, Midwifery and Quality Expiry Date 25/09/2016 Withdrawn Date This policy supersedes all previous issues. Version Control Version Release Author/Reviewer Ratified Date Changes by/Authorised (Please identify page no.) by 1.0 01/12/2006 L Swanson Trust Policy 01/12/2006 Forum 2.0 29/10/2009 J Thompson IPCN Infection, 31/07/2009 Prevention and Control Committee 3.0 24/10/2013 C Griffiths IPCN Infection, 26/09/2013 Prevention and Control Committee Central Venous Access Device Policy v3 2 Contents Section Page 1. Introduction ...................................................................................................................... 4 2. Policy scope ....................................................................................................................... 4 3. Aim of policy ..................................................................................................................... 4 4. Duties (Roles and responsibilities) ................................................................................... 4 5. Definitions ......................................................................................................................... 5 6. Central Venous Access Device Policy (Central Line Policy) ............................................... 6 6.1
    [Show full text]